NEW YORK (GenomeWeb) – EKF Molecular Diagnostics will collaborate with medical technology firm Angle for liquid biopsy development, the companies announced today.

The UK-headquartered companies aim to initially investigate applications for colorectal cancer diagnostics combining EKF's PointMan DNA enrichment technology with Angle’s Parsortix circulating tumor cell (CTC) harvesting platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.